Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bupivacaine,Meloxicam
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Heron Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Heron Partners With CrossLink Life Sciences To Expand Promotional Effort For ZYNRELEF®
Details : The partnership aims to expand the sales network supporting Zynrelef (bupivacaine and meloxicam) extended-release solution, the first and only dual-acting local anesthetic, for post-operative pain.
Brand Name : Zynrelef
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 07, 2024
Lead Product(s) : Bupivacaine,Meloxicam
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Heron Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?